Online group course for fibromyalgia, run with the patient's rheumatologist
TL;DR Achewell is a 10-week online group course for people with fibromyalgia - graded exercise led by a physiotherapist, sleep routines, and pain-coping skills taught by a psychologist. Rheumatologists refer patients and get progress reports. Patients pay per course, and the pitch is better function, not a cure.
Fibromyalgia is common and badly served. A house-to-house survey of 648 women in western India found a third living with chronic pain, and 6.17% meeting the classification criteria for fibromyalgia, in villages as often as in cities[1]. No national figure exists, so treat that as one regional reading.
The treatment gap is the bigger issue. Europe's rheumatology body rates exercise as the only strongly recommended therapy, with psychological help and structured rehabilitation as tailored add-ons[2]. A rheumatologist in India usually has ten minutes, a prescription pad and a leaflet, and that's about it. Few patients find a supervised exercise plan, and fewer still stay with one long enough for it to work.
What it does, in regulatory terms: a clinician-delivered rehabilitation and self-management service. It does not diagnose, prescribe or replace medicines. Diagnosis stays with the referring rheumatologist. If the app ever starts making treatment decisions by itself, CDSCO's medical device software guidance comes into play[3].
Groups of 8–10 meet online twice a week for 10 weeks. A physiotherapist runs a graded movement session that starts very low and steps up only when flare scores allow. A psychologist teaches pacing, sleep scheduling and ways to handle flares. Between sessions, patients log pain, sleep and steps in two minutes a day, and the rheumatologist receives a one-page summary at weeks 5 and 10.
The seed pitched VR biofeedback for chronic pain, and I've reframed it. VR pain-coping already appears in this directory, and the guideline evidence favours exercise and coping skills that need no headset. Groups also keep the cost per patient low.
Most patients are women aged 30–55, and most pay out of pocket. I'd assume ₹6,000–12,000 per 10-week course, but there is no Indian price to anchor it, so test this. Rheumatologists and pain clinics are the channel rather than the payer, and some may white-label the course for their own patients. Employers and insurers are a later, uncertain route.
A US company now markets an app as an FDA-cleared digital behavioural therapy for fibromyalgia[4], which gives doctors a reference point. In a 2024 pilot trial of digital acceptance-based therapy, 73.0% of patients reported improvement against 22.2% on symptom tracking alone[5]. India's DPDP Rules, notified in November 2025, set clear consent duties for health data[6].
There's no published figure for India's fibromyalgia care market. The bottom-up signal is the 6.17% prevalence found among women in one western Indian survey[1]. Even a small slice of patients seen in rheumatology clinics in the top eight cities would fill hundreds of groups a year. Prove this with referral counts, not a market report.
That app is US-focused and app-only[4]. One physiotherapy chain runs 28 physiotherapy clinics across three south Indian cities but lists no fibromyalgia programme[7]. Large hospital pain clinics offer injections and medicines, with exercise left to the patient. Nobody in India sells a structured, clinician-run fibromyalgia course that reports back to the rheumatologist. That gap is the opening.
| Difficulty | Moderate (33/100) |
| Starting capital | ₹40–75 L |
| Time to launch | 4–6 months |
The software is simple. The hard parts are clinical - finding physiotherapists who understand flare-paced loading, keeping patients through weeks 3–5 when soreness peaks, and earning enough trust from rheumatologists that they refer every month. Each new city also needs its own clinician bench.
No single licence covers this, but the clinicians and the software each carry rules.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
AI shouldn't change a patient's exercise dose or comment on medicines by itself. Treatment decisions stay with the clinicians and the referring doctor.
Want to work out the AI layer for Achewell? Talk to Yash →
Here's what can go south -
I like this for a physiotherapist or psychologist founder with ties to rheumatologists. It rewards patience, not hypergrowth. If you want a pure software business then skip it. First prove that two clinics will refer 20 patients a month and that 70% of a pilot group finish the 10 weeks.
Plan for roughly ₹40–75 L, mostly for clinicians, light software and the months spent winning rheumatologist referrals.
There's no single licence, but physiotherapists need allied health registration, doctor consults follow the Telemedicine Practice Guidelines and health data needs DPDP consent.
Yes, the model works anywhere with rheumatologists who need somewhere to refer. Check your local telehealth and clinician registration rules first.
The free Achewell validation kit has the line-by-line capital breakdown, the effort scoring, the rules checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for patients and rheumatologists, and 5 assumptions to test. Download the kit →
Thinking about building Achewell or something close to it? The make-or-break work is keeping patients through the painful middle weeks and getting rheumatologists to refer every month. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.